Highlights from the Herpes Cure Pipeline with Dr. Anna Wald

Highlights from the Herpes Cure Pipeline 3.0 w/ Dr. Anna Wald

September 20th 6pm EST 

Herpes Cure Advocacy Meet the Experts series returns this Fall with Dr. Anna Wald and an overview of the clinical pipeline for Herpes. Dr Anna Wald is Professor in the Department of Medicine, Epidemiology and Laboratory Medicine & Pathology at the University of Washington and in the Vaccine and Infectious Diseases Division at the Fred Hutchinson Cancer Research Center.  

Dr Wald co-directs the University of Washington Virology Research Clinic, a clinic dedicated to the study of epidemiology, natural history and therapeutics for viral infections.  Her research has focused on genital herpes infections, including infections in pregnant women and immunocompromised hosts.

Anna Wald, portrait at the Fred Hutchinson Cancer research Center, September 24, 2019, in Seattle, Washington

Dr. Wald has been an investigator in many clinical trials for novel antiviral agents and prophylactic and therapeutic vaccines for HSV infection, as well as vaccines for HPV, CMV and other viral pathogens.  Join us for a talk highlighting promising preclinical research and clinical trials for HSV, the release of Herpes Cure Pipeline 3.0, and hear Dr. Wald’s reflections on where the field has been and where it’s going. 


Overview of Prior Efforts

Promising Clinical Research

Highlights from Herpes Cure Pipeline 3.0

The Path to a Cure

Live Q&A

Want the latest news on herpes cure, treatment and prevention?
Sign up for emails to make sure you never miss a thing.

Success! You're on the list.

Leave a Reply

%d bloggers like this: